- Understanding where reducing cost versus protecting patient safety creates real tension in clinical supply
- Exploring trade-offs between speed cost and quality versus operational risk and trial integrity
- Debating when cost reduction is justified versus when it creates unacceptable risk
- Defining where efficiency gains are possible versus where quality must remain non-negotiable
- Understanding barriers to adoption
- Identifying where it adds value
- Scaling without overinvestment 15:00 Session reserved
- Understanding how IRT decisions impact clinical supply operations
- Improving responsiveness during changing enrolment and country expansion
- Reducing overproduction, waste and unnecessary shipments
- Connecting IRT data with real-time supply planning
- Sharing practical lessons from global studies
- Improving patient adherence through smart packaging and digital reminders
- Protecting medicine integrity with real-time monitoring and traceability
- Supporting decentralised trials through connected packaging solutions
- Lessons learned from implementing digital packaging in clinical trials
- Exploring the practical benefits of Digital Display Labels for improving clinical trial supply operations
- A demonstration of the functionality of DDLs; just-in-time labelling, lot & expiry update, multiple page count
- Implementing the operational framework to securely manage remote content and language updates across global clinical trials
- Key considerations for implementing DDLs across different IMP formats, including vials, bottles and blisters
- Understanding where compliance and operational risks most commonly arise in pharma air freight supply chains,
- Managing regulatory challenges, including Good Distribution Practice (GDP), and the role of CEIV Pharma in mitigating risks and ensuring compliance.
- Applying practical risk mitigation tools and planning strategies during transportation to avoid disruption and temperature excursions
